ImpriMed
Healthcare & Life Sciences
Recent Finacing
Series A
Recent Raise
$23M
ImpriMed is a precision medicine startup leveraging AI to personalize cancer treatment, initially for pets and now expanding into human oncology, with a focus on predicting drug responses.
Focus Areas
Precision Medicine
AI-Powered Cancer Treatment
Canine and Feline Oncology
Blood Cancer Tests
Drug Response Prediction
Workforce Expansion
Investors
